Australia stocks open flat as investors assess trade developments in Asia-Pacific

Australia stocks open flat as investors assess trade developments in Asia-Pacific


SHANGHAI, CHINA – APRIL 29: Pedestrians walk by lampposts decorated with Chinese national flags prior to May Day holiday on April 29, 2025 in Shanghai, China. (Photo by Wang Gang/VCG via Getty Images)

Vcg | Visual China Group | Getty Images

Australia stocks opened flat Tuesday as investors assessed trade developments between the U.S. and countries in the Asia-Pacific region, with focus also on Asian currencies that have been strengthening on the back of a declining dollar.

India has reportedly proposed zero tariffs on steel, auto components and pharmaceuticals on a reciprocal basis and up to a certain amount of imports, while Malaysia said Monday that Washington had agreed for further talks and there could be a cut in tariffs.

Treasury Secretary Scott Bessent told CNBC Monday that U.S. was “very close to some deals,” echoing comments from U.S. President Donald Trump a day earlier that there could be some agreements as early as this week.

Australia’s S&P/ASX 200 benchmark inched 0.04% higher in early trade.

China stocks will resume trading after the Labor Day holidays amid signs of Washington and Beijing taking a more conciliatory approach to resolving trade disputes after resorting to tit-for-tat tariffs.

The country’s April reading for the Caixin Services Purchasing Managers’ Index — which measures the health of China’s non-manufacturing sector — is expected later in the day.

Futures for Hong Kong’s Hang Seng index stood at 22,597 pointing to a slightly higher open compared to the HSI’s last close of 22,504.68.

Japanese and South Korean markets are closed for public holidays.

U.S. stock futures were little changed as investors awaited the start of the Federal Reserve’s first policy meeting since U.S. President Donald Trump announced “reciprocal” tariffs in early April. The two-day policy meeting will begin on Tuesday stateside, with a rate decision expected Wednesday. Fed funds futures trading points to just a 2.7% chance of a rate cut, according to the CME Group’s FedWatch tool.

Overnight stateside, stocks fell with the S&P 500 ending a nine-day rally as investors monitored the latest developments on global trade.

The broad-market index shed 0.64% to close at 5,650.38, while the Nasdaq Composite dipped 0.74% to end at 17,844.24. The Dow Jones Industrial Average dropped 98.60 points, or 0.24%, to settle at 41,218.83. The S&P 500 came into the session riding a nine-day winning streak, its longest since 2004..

— CNBC’s Pia Singh and Hakyung Kim contributed to this report.



Source

Musk’s xAI raises  billion in latest funding round
World

Musk’s xAI raises $15 billion in latest funding round

Elon Musk announced his new company xAI, which he says has the goal to understand the true nature of the universe. Jaap Arriens | Nurphoto | Getty Images Elon Musk’s artificial intelligence company xAI has raised $15 billion from investors, sources familiar with the matter told CNBC’s David Faber. The funding adds another $5 billion […]

Read More
Starbucks workers union launches strike in more than 40 cities on chain’s key holiday sales day
World

Starbucks workers union launches strike in more than 40 cities on chain’s key holiday sales day

Workers picket in front of a Starbucks outlet in New York City, U.S., Oct. 1, 2025. Brendan McDermid | Reuters Starbucks Workers United launched an open-ended strike in more than 40 cities Thursday on Red Cup Day, one of the chain’s biggest sales days of the year. The protest, which the union says involves more than […]

Read More
WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launch
World

WeightWatchers to offer Novo Nordisk’s Wegovy pill after 2026 launch

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images WeightWatchers’ CEO said on Wednesday it plans to offer Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker. The […]

Read More